-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Transcode Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from 2021 to 2024.
- Transcode Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $32.2K, a 8.52% increase year-over-year.
- Transcode Therapeutics, Inc. annual Depreciation for 2024 was $90.9K, a 26.4% decline from 2023.
- Transcode Therapeutics, Inc. annual Depreciation for 2023 was $123K, a 25.2% increase from 2022.
- Transcode Therapeutics, Inc. annual Depreciation for 2022 was $98.6K, a 132% increase from 2021.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)